PC

Pradeep Chawla

Active Director Director DIN 02759412
DIN 02759412 First appointment Jan 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2010
Shareholding value •••• Premium profile

About Pradeep Chawla

Data last updated:

Pradeep Chawla is a Director at Maxamus Pharma Private Limited (since 2010). The company operates in Pharma. Maxamus Pharma Private Limited reported revenue of ₹8.59 Cr (FY 2016).

DIN 02759412
Primary Designation Director
Industry Pharma
First Appointment 15 Jan 2010
Oldest Company Age 16 yrs
Largest company Maxamus Pharma Private Limited · ₹8.59 Cr (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maxamus Pharma Private Limited U74900DL2010PTC198065
Director15 Jan 20102010₹8.59 Cr (FY 2016)Active

Board colleagues of Pradeep Chawla

NameDINCompanyDesignation
Vikas Bhatnagar02768015Maxamus Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maxamus Pharma Private Limited
Premium access

Shareholding and investment profile for Pradeep Chawla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pradeep Chawla

Pradeep Chawla currently holds 1 directorship: Maxamus Pharma Private Limited (Director, since 15 Jan 2010, revenue ₹8.59 Cr (FY 2016)).

Pradeep Chawla was first appointed on 15 Jan 2010 as Director at Maxamus Pharma Private Limited.

The current boards of Pradeep Chawla's companies include Vikas Bhatnagar (Maxamus Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available